8 More Big Pharma Events in 2019 You Don't Want to Miss
These are the clinical trial readouts, FDA decisions, and blockbuster-drug launches that will set the tone for the entire industry.
Editors' Picks
Tesla Cuts Prices Again. It's Not Good News.
Frequent price changes might boost sales in the short run, but they will hurt profitability and could damage Tesla's brand in the long run.
NextEra Energy: U.S. Can Hit 50% Renewable Energy by 2030
The world's largest producer of electricity from the wind and sun is surprisingly optimistic about the future of renewable energy.
The 10 Biggest Food Stocks
You might not even think of the top two as food stocks, but they very much are.
Recent articles
4 Reasons Theme Parks Are Struggling This Summer
It's easy to see what Disney, Universal Studios, and SeaWorld got wrong in Central Florida this season.
Bank of America Keeps This Amazing 4.5-Year Streak Alive
The big bank keeps finding a way to get more profitable.
You May Need More Retirement Income if This Scenario Applies to You
It's a good position to be in, in theory, but a financially precarious one in practice.
Adding Beyond Meat to Its Menu Won't Save Blue Apron
The market reacted irrationally to news that the meal kit maker would offer the popular plant-based burgers.
Will Coca-Cola Earnings Stay Flat in the Second Quarter?
Don't be surprised by a growth slowdown in the beverage giant's upcoming report, scheduled for release Tuesday.
Tesla Cuts Prices Again. It's Not Good News.
Frequent price changes might boost sales in the short run, but they will hurt profitability and could damage Tesla's brand in the long run.
NextEra Energy: U.S. Can Hit 50% Renewable Energy by 2030
The world's largest producer of electricity from the wind and sun is surprisingly optimistic about the future of renewable energy.
The 10 Biggest Food Stocks
You might not even think of the top two as food stocks, but they very much are.
Interactive Brokers Has a Plan to Lure Sports Bettors to Investing
Bet. Learn. Win. Start a brokerage account?
8 More Big Pharma Events in 2019 You Don't Want to Miss
These are the clinical trial readouts, FDA decisions, and blockbuster-drug launches that will set the tone for the entire industry.
The 9 Biggest Tobacco Stocks
There aren't a huge number of U.S.-listed stocks with a tobacco focus, but these companies still combine to be a force in the global industry.
2 Stocks You Can Buy and Hold Forever
These stocks are well-positioned to benefit from this multi-decade trend.
How Bad Will Harley-Davidson's Q2 Report Be?
All signs point towards another depressing quarter of domestic sales declines -- but the motorcycle maker's focus is elsewhere.
Can Facebook Get Past the Antitrust Debacle When It Reports Earnings?
After recent reports of a record-setting fine, it needs to put its history of consumer privacy issues behind it.
Netflix Just Failed a Big Test
The streaming video leader's oldest markets are starting to become saturated. Moreover, Netflix doesn't have as much pricing power as many bulls seem to believe.
Domino's Pizza Will Be Just Fine During the Delivery Wars
More than just a pizza chain, Domino’s is diving headlong into the world of data-driven expansion and automation technology.
Is Duke Energy a Buy?
The utility sector has done well so far in 2019, but Duke Energy has severely lagged its peers. What's going on?
Can PayPal Continue Win Streak When It Reports Q2 Earnings?
The company has made an unexpected strategic investment to expand its payment processing empire.
2 Stocks to Buy That Have Dividends Yielding More Than 5%
Finding a 5% yield in a world where the S&P is offering less than 2% doesn't need to come with massive risk. Here's the proof.
A Comprehensive Look at U.S. Dispensary Stocks Following Curaleaf's Big Acquisition
Curaleaf's $875 million deal to buy Grassroots shakes up the multistate dispensary leaderboard.